Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is evaluate the efficacy of 3D185 in subjects with advanced/metastatic cholangiocarcinoma with FGFR2 Gene Alterations who have failed at least 1 previous treatment.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05039892
Study type Interventional
Source 3D Medicines
Contact silong xiang, MD
Phone ( 86)15901312398
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date June 2022
Completion date December 2026